DEAR GUESTS, It is my honor and privilege to invite you to the third international Forum "Life Sciences Baltics 2016", which will be held in Vilnius, Lithuania, on September 14-15, 2016. This bi-annual international science and business conference is the largest gathering of all life sciences specialists in the entire Central and Eastern Europe. Furthermore, with the special focus on three Baltic countries Lithuania, Latvia and Estonia the forum attracts numerous delegations from the leading countries, which are interested in discovering the Baltic region potential in the field of life sciences. THIS IS THE LARGEST GATHERING OF ALL LIFE SCIENCES SPECIALISTS IN THE ENTIRE CENTRAL AND EASTERN EUROPE. Since the future belongs to the bio-economy which is going to be based on the concrete results of the Life Sciences sector, it becomes crucial to turn it into a national priority. In order to improve international competitiveness and economic vibrancy in Lithuania, governmental institutions, and the whole science and business ecosystem join their forces to establish an open and friendly environment for attracting the progressive mind, break-through ideas and forming the new effective networks with partners from all over the world. Lithuania already hosts one of the most innovative hubs in Europe: 16 academic institutions, 15 most competent R&D centers along with the pool of over 15,000 specialists and researchers as well as nearly 200 companies operating in the sector, science parks, and innovation valleys. They provide the country with the most necessary tools to succeed in becoming one of the top high tech innovation centers in Europe or even the world. A nation with a population of only 3 million is among the top EU countries by the percentage of specialists with higher education. Universities currently train in physics and life sciences almost 9000 students, 1200 of these prospective inventors graduate every year. We have increased state financed places at universities and colleges for life science disciplines to ensure intellectual capacity for future growth. This decision is followed by prioritizing respective disciplines in the curriculum of high schools nation-wide. It is important to highlight that The Forum enjoys high participation by local and international corporations and investors who attend this conference to notice tomorrow s potential in today s products. We are committed to promote a closer international cooperation between science and business in the fields of biotechnology, medical equipment, devices and pharmacy. The Forum also provides a platform for startups to meet ˆ ALGIRDAS BUTKEVICIUS, PRIME MINISTER, REPUBLIC OF LITHUANIA up with partners and investors. It is the ultimate place to be exposed in the clinical trials, meet the venture capital experts, boost ideas and begin cooperating further. Join over 1000 business leaders and scientists at the Forum, meet potential partners, discover new opportunities, and share ideas for the new and prosperous future of humanity. Our country would be delighted to welcome you at "Life Sciences Baltics 2016".
WHY BALTICS? BSR 110 million ESTONIA LATVIA TREND-SETTER DESTINATIONS IN EU EUROPE S PRIME LOCATION AND INFRASTRUCTURE EU 340 million LITHUANIA CIS 250 million Crossroads of North, East and West 3 Pam-European transport corridors 4 modern international airports *BSR The Baltic Sea Region CIS The Commonwealth of Independent State
WHY BALTICS? EU STRUCTURAL FUNDS. Cooperation with Baltic companies enables access to the EU structural funds (only in Lithuania up to 1 billion EUR for the period of 2014-2020) START-UPS. A GROWING NUMBER OF START-UPS AND SMES HAVE ADVANCED PRODUCT PORTFOLIO AND WOULD LIKE TO ATTRACT PARTNERS FOR FINANCIAL INVESTMENTS COMPETITIVE SALARIES. Gross salaries in the life sciences sector are 2 to 3 times more competitive compared to Western Europe TALENTS. Region offers highly qualified talent pool TAXES. Astonishing tax environment for R&D activities
WHY BALTICS? ESTONIA: LATVIA: LITHUANIA: 1ST COUNTRY TO OFFER E-RESIDENCY - A TRANSNATIONAL DIGITAL IDENTITY AVAILABLE TO ANYONE IN THE WORLD INTERESTED IN ADMINISTERING A LOCATION-INDEPENDENT BUSINESS ONLINE 1st country in the world to hold nation-wide elections using i-voting More than 90% of the people complete their income tax return over the internet Data visualization has reached new peaks with the help of Latvians (Infogr.am) Libraries house not only numerous hard copy books, but are being digitized and uploaded online QUEUING IS AVOIDED BY USING ALMOST 100 STATE AND LOCAL GOVERNMENT E-SERVICES Fastest public Wi-Fi in the world and leading upload broadband speed in the EU and top 5 globally 1ST IN ENTREPRENEURSHIP BY IMD WORLD COMPETITIVENESS RANKING Highest ICT literacy in the EU 97% of students obtaining ICT skills in secondary schools 1st in CEE in University-Industry collaboration in R&D
LIFE SCIENCES IN ESTONIA: 1866 AROUND 150 COMPANIES IN BIOTECHNOLOGY AND LIFE SCIENCES 9 ACADEMIC EXPERTS UNIVERSITIES AND RESEARCH INSTITUTES WITH R&D IN BIOTECHNOLOGY AND LIFE SCIENCES THERE ARE 4 BIOMEDICAL CLUSTERS AND 3 BIOMEDICAL COMPETENCE CENTERS IN ESTONIA 66 PH.D. GRADUATES PER YEAR 507 MASTER GRADUATES PER YEAR 1.841 BACHELOR GRADUATES PER YEAR LEADING SUBSECTOR: GENETICS & HEREDITY, CREATING 33,7% OF INDUSTRY PRODUCTION 28% THE ANNUAL TURNOVER OF THE ESTONIAN BIOTECHNOLOGY IS GROWING AT A RATE OF 28% 33,7%
LIFE SCIENCES IN LATVIA: LEADING SUBSECTOR: PHARMACEUTICALS. IT IS THE LARGEST INDUSTRY SUB-SECTOR, CREATING 33% OF INDUSTRY PRODUCTION NR. 4 33% LIFE SCIENCE SECTOR IS 4TH BY TURNOVER AMONG MANUFACTURING INDUSTRIES IN LATVIA 50 TOTAL NUMBER OF LIFE SCIENCES COMPANIES, R&D CENTERS, UNIVERSITIES CHEMICAL AND PHARMACEUTICAL SECTOR GIVES 9.4% (2010) OF GROSS DOMESTIC PRODUCT AND ACCOUNTS FOR 10% OF THE TOTAL NATIONAL EXPORT NOBEL PRIZE WINNER: PAUL VALDEN WAS NOMINATED TWICE FOR THE NOBEL PRIZE AND IS A FOUNDER OF PHYSICAL ORGANIC CHEMISTRY NOBEL PRIZE WINNER: WILHELM OSTWALD IN CHEMISTRY IN 1909 FOR HIS WORK ON CATALYSIS, CHEMICAL EQUILIBRIA AND REACTION VELOCITIES
LIFE SCIENCES IN LITHUANIA R&D SECTOR ACHIEVED GROUND BREAKING RESULTS IN THE FIELDS OF: PHARMACEUTICAL PROTEINS CHEMISTRY BIOCHEMISTRY OF ENZYMES AND NUCLEIC ACIDS MOLECULAR BIOLOGY OF PROKARYOTE AND EUKARYOTE CURRENT SPOTLIGHT OF RESEARCH POINTED ON BIOINFORMATICS 3x FASTER GENES CUT, BASED ON ADVANCED ENZYMES METHODOLOGY, FOUND IN LITHUANIA Labor productivity in pharmaceuticals sector is almost 5 times (in 2011) higher than the overall economy s labor productivity TOTAL ANNUAL REVENUES EXCEED: 75 000 000 23% ANNUAL GROWTH 15 000 R&D researchers and scientists in various fields EXPENDITURES FOR R&D grew by 14% in 2014 R&D ORIENTED: 10TH IN THE WORLD FOR R&D PERSONNEL PER CAPITA (MAD, 2013) PRODUCTION IS EXPORTED TO OVER 100 COUNTRIES 16 RESEARCH CENTRES cooperating with both domestic and foreign biotechnology companies and universities 11% YEAR ON YEAR RISE IN R&D EXPENDITURE SINCE 2005 (LITHUANIAN STATISTICS, 2013)
LASERS LITHUANIA, WITH 10% OF THE GLOBAL MARKET, IS ONE OF THE MAIN EXPORTER OF FEMTOSECOND* LASERS SYSTEMS IN THE WORLD *FEMTOSECOND = 0.000 000 000 000 000 1 S. CLIENTS AND PARTNERS OF LITHUANIAN LASER MANUFACTURERS INCLUDE: NASA The Nuclear Research Centre in Israel Rutherford Laboratories in England 80% Berkeley University in the USA The Livermore National Laboratory, etc 80% 80% OF THE GLOBAL PRODUCTION OF ULTRA-FAST PARAMETRIC AMPLIFIERS OF TOTAL LITHUANIAN LASER PRODUCTION EXPORTED TO NEARLY 100 COUNTRIES (KEY MARKETS: USA, GERMANY, JAPAN) CONTINUOUS INDUSTRY GROWTH REACHING 20% PER YEAR Laser manufacturing sector of Lithuania shows a 15-20% growth per year 15-20% EVERY 10TH SCIENTIFIC LASER USED IN THE WORLD IS PRODUCED IN LITHUANIA
MEDICAL DEVICES EDUCATION MEDICAL DEVICES EXPORTS (incl. re-exports) more than doubled since 2008 180 M 177 M 2008 2012 2014 1ST -IN EU FOR SHARE OF GRADUATES IN TOTAL POPULATION -IN CEE FOR QUALITY OF MATH AND SCIENCE EDUCATION (WEF GLOBAL COMPETITIVENESS REPORT, 2014-2015) MAIN EXPORT COUNTRIES ARE: UNITED KINGDOM FRANCE RUSSIA SPAIN USA Research areas include biomedical diagnostics and monitoring systems, efficiency research of electronic security systems, analysis and synthesis of electronic devices, quality of electronic systems INDUSTRIAL ELECTRONICS, INCLUDING MEDICAL AND DEFENSE ELECTRONICS HAS BEEN A PREVALENT APPLICATION SECTOR IN ELECTRONICS MANUFACTURING WITH TELECOMMUNICATION EQUIPMENT BEING A KEY GROWING SEGMENT 9000 LIFE SCIENCE STUDENTS AT UNIVERSITIES AND COLLEGES 1200 GRADUATES EACH YEAR
CLINICAL TRIALS Clinical trials in Lithuania cover a range of therapeutic areas ENDOCRINOLOGY GASTROENTEROLOGY RHEUMATOLOGY PULMONOLOGY INFECTOLOGY DERMATOLOGY UROLOGY PEDIATRIC SURGERY NEPHROLOGY CARDIOLOGY PSYCHIATRY HEMATOLOGY NEUROLOGY ONCOLOGY OPHTHALMOLOGY 1200 SINCE 2006 THERE WERE 1200 CLINICAL TRIALS ONGOING IN THE COUNTRY 90 INTERNATIONAL PHARMA AND MEDICAL COMPANIES ARE CONDUCTING CLINICAL TRIALS IN LITHUANIA BUSINESS-FRIENDLY ENVIRONMENT STRATEGIC LOCATION FAVORABLE TAX INCENTIVES FOR INVESTMENTS INTO R&D INCLUDING: TRIPLE DEDUCTION: expenses incurred by companies while carrying out R&D can be deducted from taxable income tree times SUPER-ACCELERATED DEPRECIATION: the acquisition price of fixed assets used in the R&D activities can be writtenoff within two years INVESTMENTS INTO SUBSTANTIAL TECHNOLOGICAL IMPROVEMENTS, entitle companies to reduce taxable profits by 50% FIND MORE AT WWW.LSB2016.COM
LIFE SCIENCES BALTICS NEW DESTINATION FOR LIFE SCIENCES TREND-SETTERS LIFE SCIENCES BALTICS 2016 FOCUS ON: Within 2012 and 2014: VISITORS FROM 40 AROUND COUNTRIES 1900 ATTENDEES AGE-RELATED DESEASES BIO-BANKING PRECLINICAL AND CLINICAL TRIALS MOLECULAR MEDICINE REGENERATIVE MEDICINE TECHNOLOGY TRANSFER AND INNOVATION MANAGEMENT PHARMACEUTICALS AND BIOPHARMACEUTICALS MEDICAL DEVICES 3000 B2B MEETINGS EXHIBITORS 100 LITHUANIAN AND FOREIGN COMPANIES
WHY A MUST? 1 MORE THAN 1000 KEY SECTOR PLAYERS AND DECISION MAKERS FROM MORE THAN 40 COUNTRIES (INCLUDING DELEGATIONS FROM US, ISRAEL, EU), REGULATORY BODIES AND GOVERNMENT REPRESENTATIVES 3 NOBEL PRIZE WINNERS AND GLOBALLY ACCLAIMED SPEAKERS 5 FOCUS ON NETWORKING AND ESTABLISHING PARTNERSHIPS 2 INVESTOR-READY STARTUPS 4 EU STRATEGY, DIRECTIONS AND FUNDING OPPORTUNITIES 6 TALENT POOL AND STATE-OF-THE- ART SCIENTIFIC INFRASTRUCTURE OF THE BALTIC COUNTRIES 3rd Life Sciences Baltics 2016 is the only international forum in the Baltic region for worldclass biotechnology, pharmaceutical and medical experts from around the world, reoccurring every two years. It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking. DISCOVER ENORMOUS POTENTIAL IN THE FIELD OF LIFE SCIENCES IN LITHUANIA AND THE BALTIC REGION THE GATEWAY TO EMERGING MARKETS
SAVE THE DATE! SEPTEMBER 14-15, 2016 Enterprise Lithuania offers high quality services meeting business needs and expectations. The knowledge and expertise of our professional team, gained through direct dealing with the country s companies and exporters, will help you to find the best and most reliable suppliers of products, services and technologies in Lithuania. We aim at finding a reliable and long-term partners. We work locally, but thing globally. A multicultural approach helps to better understand and evaluate the needs and interests of foreign clients. Main organizer: To arrange a meeting please contact us: info@lsb2016.com, www.lsb2016.com For more information visit: www.enterpriselithuania.com